Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alouani

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 18, 2023
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line settingBahar Saberzadeh-Ardestani, Jeremy C Jones, Robert R McWilliams, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2026
From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancerMargherita Ambrosini, Claire Gallois, Annalice Gandini, et al.
European Journal of Haematology|September 21, 2024
Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023Matteo Guerra, Emily Alouani, Thomas Hueso, et al.
The Journal of Clinical Investigation|December 19, 2001
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritisC Plater-Zyberk, L A Joosten, M M Helsen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2024
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancerMargherita Ambrosini, David Tougeron, Dominik Modest, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncologyEmily Alouani, Ariane Laparra, Audrey Perret, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
The Journal of Physical Chemistry Letters|June 9, 2016
High Spin Polarization at Ferromagnetic Metal-Organic Interfaces: A Generic PropertyFatima Djeghloul, Manuel Gruber, Etienne Urbain, et al.
Nano Letters|November 18, 2015
Spin-Dependent Hybridization between Molecule and Metal at Room Temperature through Interlayer Exchange CouplingManuel Gruber, Fatima Ibrahim, Samy Boukari, et al.
JAMA Oncology|October 19, 2023
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction AdenocarcinomaGulam A Manji, Shing Lee, Armando Del Portillo, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|November 18, 2023
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line settingBahar Saberzadeh-Ardestani, Jeremy C Jones, Robert R McWilliams, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2026
From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancerMargherita Ambrosini, Claire Gallois, Annalice Gandini, et al.
European Journal of Haematology|September 21, 2024
Relevance, Risks, and Benefits of Early-Phases Clinical Trials Participations for Patients With Hematological Malignancies From 2008 to 2023Matteo Guerra, Emily Alouani, Thomas Hueso, et al.
The Journal of Clinical Investigation|December 19, 2001
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritisC Plater-Zyberk, L A Joosten, M M Helsen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2024
BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancerMargherita Ambrosini, David Tougeron, Dominik Modest, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2023
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncologyEmily Alouani, Ariane Laparra, Audrey Perret, et al.
Journal for Immunotherapy of Cancer|January 4, 2025
Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitorsJulien Taieb, Margherita Ambrosini, Emily Alouani, et al.
The Journal of Physical Chemistry Letters|June 9, 2016
High Spin Polarization at Ferromagnetic Metal-Organic Interfaces: A Generic PropertyFatima Djeghloul, Manuel Gruber, Etienne Urbain, et al.
Nano Letters|November 18, 2015
Spin-Dependent Hybridization between Molecule and Metal at Room Temperature through Interlayer Exchange CouplingManuel Gruber, Fatima Ibrahim, Samy Boukari, et al.
JAMA Oncology|October 19, 2023
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction AdenocarcinomaGulam A Manji, Shing Lee, Armando Del Portillo, et al.
Pageof 17